OTC · FWPAY
Forward Pharma A/S
Healthcare · Biotechnology
$300.00
Down-$100.50 (-25.09%)
Updated Sep 20, 2026, 3:11 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 7.45M
- P/E ratio
- -3.88
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 4
- Avg. volume
- 10
Price performance
FWPAY price history
1M range · 0 trading sessions · Daily adjusted prices
FWPAY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest FWPAY news
The latest Smart Investors Daily articles mentioning FWPAY.
Stock researchCompany · Overview
FWPAY research
Overview
Company profile and research snapshot.
Company profile
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
